Table 4 Descriptive statistics on data from patients who were and were not tested for SVR
From: Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
| Â | Total (%) | Tested for SVR (%) | Not tested for SVR (%) |
|---|---|---|---|
N (189) | 189 (100%) | 177 (94%) | 12 (6%) |
Age at treatment, years [mean (sd)] (p-value 0.8764) | 56 (8.7)a | 56 (8.7)a | 56 (8.9)a |
Sex (p-value 0.8347) | |||
 Male | 89 (47%) | 83 (93%) | 6 (7%) |
 Female | 100 (53%) | 94 (94%) | 6 (6%) |
Race (p-value 1.0000) | |||
 White | 133 (70%) | 124 (93%) | 9 (7%) |
 Black | 52 (28%) | 49 (94%) | 3 (6%) |
 Asian/other | 4 (2%) | 4 (100%) | 0 (0%) |
Ethnicity (p-value 0.5565) | |||
 Hispanic | 111 (59%) | 105 (95%) | 6 (5%) |
 Non-Hispanic | 78 (41%) | 72 (92%) | 6 (7%) |
Race/ethnicity (p-value 0.3681) | |||
 Hispanic | 111 (59%) | 105 (95%) | 6 (5%) |
 Non-Hispanic white | 30 (16%) | 26 (87%) | 4 (13%) |
 Non-Hispanic black | 45 (24%) | 43 (96%) | 2 (4%) |
 Asian/other | 3 (2%) | 3 (100%) | 0 (0%) |
Insurance (p-value 0.7516) | |||
 Yes | 56 (30%) | 52 (93%) | 4 (7%) |
 No | 133 (70%) | 125 (94%) | 8 (6%) |
Compliance (p-value < 0.0001) | |||
 Yes | 156 (83%) | 156 (100%) | 0 (0%) |
 No | 33 (17%) | 21 (64%) | 12 (36%) |
Complications (p-value 0.8645) | |||
 Yes | 99 (52%) | 93 (94%) | 6 (6%) |
 No | 90 (48%) | 84 (93%) | 6 (7%) |
Pre-treatment viral load, IU/mL [median (range)] (p-value 0.6178) | 1,675,814 (840–166,211,511)b | 1,675,814 (840–166,211,511)b | 1,542,867 (95,425–19,635,228)b |
Genotype (p-value 0.1868) | |||
 1 | 153 (81%) | 144 (94%) | 9 (6%) |
 2 | 18 (9%) | 18 (100%) | 0 (0%) |
 3 | 11 (7%) | 9 (82%) | 2 (18%) |
 4 | 6 (3%) | 5 (83%) | 1 (17%) |
 Mixed | 1 (0.46%) | 1 (100%) | 0 (0%) |
Cirrhosis (p-value 0.2169) | |||
 Yes | 68 (36%) | 66 (97%) | 2 (3%) |
 No | 121 (64%) | 111 (92%) | 10 (8%) |